Lower Abdominal Pain Treatment in India โ Causes, Diagnosis & Best Hospitals
08/23/2024
A gastrointestinal stromal tumor is a type of cancer that occurs in the digestive system. Gastrointestinal stromal tumors are most commonly present in the stomach and small intestine. GIST grows slowly and for this reason in the initial stage of cancer, the GIST usually causes no symptoms. But when the cancer is in a more aggressive stage, it shows signs and symptoms. GIST is more commonly present in adults but it can present at any age. In children, GIST is rare. The cause of GIST is unknown most of the time but it is said it tends to spread through generations. Treatments are different at different stages of the cancer and doctors usually plan treatment according to the nature of cancer cells and the extent of cancer cells or spread in the area. However, the treatment has some side effects and it can lower the quality of life of the patient. So support during the treatment and counseling with family and patient is an important part of the care of the patient. In some cases, after the treatment, GIST can return and for this reason, treatment continues even after the cure of the cancer.ย
Learn about surgery, targeted therapy (like imatinib), and follow-up care.
There are many types of treatment of GIST according to the stage and nature of cancer cells. These are:
Chemotherapy is a treatment option that kills the cancer cells by limiting their growth. Chemotherapy is often used to treat aggressive cancers. This is not usually used in the treatment of GIST. But if target drug therapy is not responding, chemotherapy treatment is used.
Radiation therapy uses strong X-rays to kill the cancer cells. Radiation therapy is used in some specific cases such as bleeding in the stomach or intestine or when it is not possible to remove a tumor with surgery.
Surgery is the first treatment option for GIST. In this treatment, the tumor is removed from the stomach or intestine. The surgeon may remove the complete or part of the affected organ according to the size, location, and extent of the tumor. Surgery is particularly effective when the tumor is small and has not spread to other parts of the body.
Targeted therapy involves using drugs that specifically target the proteins and stop their activity which helps in slowing down the growth of the tumor. Target therapy can be used in combination with surgery to prevent the recurrence of tumors.
Ablation therapy is a minimally invasive procedure used to destroy abnormal tissue such as tumors. This can be done without the need for traditional surgery. There are different techniques for ablation which include: Radiofrequency Ablation (RFA): This method uses high-frequency electrical currents to heat and destroy tumor cells. Microwave Ablation: This technique uses microwave energy to heat and destroy the tumor. Cryoablation: In this approach, extreme cold is used to freeze and destroy the abnormal tissue. Laser Ablation: A laser is used to deliver intense heat to the tumor and causes it to shrink and die.
Some of the methods that are used in the diagnosis of GIST are:
The doctor takes the medical history of a patient and then performs a physical examination of the patient to make a diagnosis of the patient.
A biopsy is a diagnostic method that confirms the presence of tumor cells in the stomach or intestine. In this test, a tissue sample is obtained during endoscopy and then tested under laboratory conditions to check if the GIST is the diagnosis. Biopsy can also tell about the nature of tumor cells and help in treatment planning.
Molecular testing is performed to find out any abnormal or diseased gene present. Molecular testing can identify specific genetic changes that are associated with GISTs.
The cost of GIST treatment in India ranges from 6,000 USD to 8,400 USD. The cost can vary according to the condition of each patient. The cost can also vary according to the stage of cancer and the response to treatments.
Some of the symptoms of gastrointestinal stromal tumors are:
Some of the risk factors for GIST are as follows:
GISTs can occur at any age but they more commonly occur in adults, particularly in those over the age of 40.
GISTs occur more frequently in men than in women. So men are at greater risk of GIST than women.
Certain genetic changes are linked to the development of GISTs. These changes can pass from one generation to another or can occur in any lifetime of a person.
There is a positive correlation between the positive family history of GIST and the development of GIST in a person. However, it occurs only in some people.
Individuals with some specific genetic disorder in which there is growth of tumors along nerves of the digestive system have an increased risk of developing GISTs.
Any past treatment of radiation therapy can increase the risk of gastrointestinal stromal tumors. The risk is higher if radiation therapy is applied to the abdominal area.
Some of the types of syndromes can increase the risk of tumors in the digestive system.
Oncologists skilled in managing rare tumors like GIST.
Advanced facilities equipped to treat gastrointestinal stromal tumors.
Targeted therapies like imatinib are highly effective in managing Gastrointestinal Stromal Tumors (GIST) because they specifically inhibit the growth of cancer cells by targeting and blocking the abnormal proteins produced by the tumor. Imatinib works by blocking the KIT and PDGFRA proteins that are often mutated in GIST, thus slowing tumor growth and reducing the risk of metastasis. This therapy is particularly beneficial for patients with advanced or metastatic GIST, offering a personalized treatment approach that focuses on the genetic characteristics of the tumor.
India is recognized for accurate diagnosis and advanced treatment of rare gastrointestinal (GI) tumors like GIST due to its world-class medical infrastructure, skilled oncologists, and advanced diagnostic technologies. Indian hospitals are equipped with the latest imaging techniques (such as CT scans, MRIs, and endoscopic ultrasound) and molecular testing to accurately diagnose GIST and other rare GI tumors. The use of personalized medicine and targeted therapies, combined with access to advanced clinical trials, makes India a leading destination for rare cancer treatment.
Indian oncology teams collaborate closely for the surgical and medical management of GIST through a multidisciplinary approach. Surgeons, medical oncologists, radiologists, and pathologists work together to develop a comprehensive treatment plan for each patient. Surgery is often the first line of treatment for localized GIST, followed by targeted therapy like imatinib for adjuvant treatment. Regular follow-up care, including imaging and genetic testing, ensures that any recurrence or metastasis is managed promptly, providing patients with the best chance of long-term survival.
Indian hospitals offer advanced genetic testing for GIST, including sequencing to identify mutations in the KIT and PDGFRA genes, which are commonly associated with GIST. Based on the results, oncologists can provide personalized treatment plans that include targeted therapies like imatinib or second-line options for drug-resistant cases. Personalized medicine ensures that treatments are tailored to the specific genetic profile of the tumor, optimizing effectiveness and minimizing unnecessary side effects.
International patients benefit from continuous monitoring and affordable GIST treatment in India through the countryโs advanced healthcare system and robust medical tourism infrastructure. Indian hospitals offer seamless coordination for diagnosis, treatment, and follow-up care, ensuring that international patients receive continuous support throughout their treatment journey. Additionally, telemedicine services allow for remote consultations and follow-ups after the patient returns home, providing easy access to ongoing care. Indiaโs cost-effective treatment options make it an attractive destination for international patients seeking high-quality GIST care at a fraction of the cost in other countries.